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III. ABSTRACT 
The bladder constitutes the most frequent localization of malignant tumours in the urinary 
tract and it is one of the common urological malignancies occurring worldwide in both 
sexes. Local literature on bladder cancer are rather scare and hence the need for a study 
of this nature. 
Sixty-seven patients with cancer of the bladder treated in a period of ten years from 1996 
to 2005 at Hospital Universiti Sains Malaysia were studied to determine the pattern of the 
disease and highlight the clinical presentation, cystoscopic finding, histopathology and 
modalities offered for treatment of the disease. 
It was found that the mean age of occurrence was 64.5 years. Male to female ratio was 
5.7: 1 and predominantly affecting the Malays (86.57%). Sixty-one percent smoker with 
significant statistical correlation to tumour grade. The most common clinical 
presentations were haematuria (85.1 %). Transitional cell carcinoma was found in 95.5% 
of studied population and most patients present with invasive stage (64.2%). TUR was 
done for 83.6% of them while 28.4% of patients underwent systemic chemotherapy 
therapy and 4.5% underwent radiotherapy. 
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1. INTRODUCTION 
Bladder carcinoma is one of the common urological malignancies occurring worldwide 
in both sexes, it is one of the first cancers associated with industrialization. Therefore, it 
is expectedly increasing in incidence in this country. 
Though the medical community has not yet succeeded in significantly lowering the 
incidence of this largely preventable cancer, they succeeded in improving the treatment 
of the disease; however, the increase in mortality emphasizes the need for further 
improve prevention, detection, and treatment. 
For early detection, we have to be familiar with mode of presentation and 
epidemiological variation of the disease especially in multi racial community like 
Malaysia. Superficial or non-invasive bladder cancer is potentially curable with minimal 
invasive surgery. However, this depends on the early detection with visualization of the 
interior of urinary bladder by cystoscopy for those who present with haematuria, which 
is the commonest presenting symptom of the disease. 
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Urology unit in Hospital Universiti Sains Malaysia, Kubang Kerian being a tertiary 
referral center received most of these cases with suspected cancer bladder from the state 
of Kelantan and nearest states. Availability of the relevant equipments, facilities as well 
as the expertise allow for institution of proper surgical and other appropriate treatment 
modalities. 
The aim of this retrospective study is to determine the disease pattern in patients with 
cancer bladder in hospital universiti sains Malaysia regarding age, sex and race of 
patients, to highlight clinical presentation and stage of disease at time of presentation, as 
well as cystoscopic and histopathological findings. Modalities of treatments offered in 
HUSM would also review. 
It is hope that results of this study will enrich the local literature on various aspect of 
bladder cancer management in this locality. 
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2. LITERATURE REVIEW 
2.1 ANATOMY OF THE URINARY BLADDER 
2.1.1 General Description 
Urinary bladder is a musculomembranous sac, which acts as a reservoir for the urine; its 
size, position, and relations vary according to the amount of fluid it contains, age and 
sex. The empty bladder has the form of a flattened tetrahedron, with its vertex (apex) 
tilted forward. It presents a fundus, a vertex, a superior and an inferior surface. The 
fundus directed downward and backward toward the rectum, from which it is separated 
by the rectovesical fascia, the vesicule seminales, and the terminal portions of the ducts 
deferentes. The vertex is directed forward toward the upper part of the symphysis pubis, 
and from it the middle umbilical ligament is continued upward on the back of the 
anterior abdominal wall to the umbilicus. The superior surface is triangular, bounded on 
either side by a lateral border, which separates it from the inferior surface, and behind 
by a posterior border, represented by a line joining the two ureters, which intervenes 
between it and the fundus. The lateral borders extend from the ureters to the vertex, and 
from thetn the peritoneum is carried to the walls of the pelvis. The superior surface is 
directed upward, is covered by peritoneum, and is in relation with the sigmoid colon 
and some of the coils of the small intestine. The inferior surface is directed downward 
and is uncovered by peritoneum. The infero-lateral portions of the inferior surface are 
directed downward and lateralward: in front, they are separated from the symphysis 
pubis by a mass of fatty tissue, which is named the retropubic pad; behind, they are in 
contact with the fascia which covers the Levatores ani and Obturatores interni (Gray, 
2000). 
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CITED FROM GRAY'S ANATOMY OF HUMAN BODY 
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When the bladder is empty, it is placed entirely within the pelvis, below the level of the 
obliterated hypogastric arteries, and below the level of the ductus deferentes. As the 
viscus fills, its fundus being less fixed, its superior surface gradually rises into the 
abdominal cavity, carrying with it its peritoneal covering, and at the same time rounding 
off the posterior and lateral borders. When the bladder is moderately full it contains 
about 0.5 liter and assumes an oval form; the long diameter of the oval measures about 
12 em. and is directed upward and forward. 
2.1.2 The Female Bladder 
In the female, the bladder is anterior to the uterus and the upper part of the vagina. It is 
separated from the anterior surface of the body of the uterus by the vesicouterine fossa, 
but below the level of this fossa it is connected to the front of the cervix uteri and the 
upper part of the anterior wall of the vagina by areolar tissue, this area is known as the 
base of the bladder. (Figure 1) 
2.1.3 Interior of the Bladder 
The mucous membrane lining the bladder is, over the greater part of the viscus, loosely 
attached to the muscular coat, and appears wrinkled or folded when the bladder is 
contracted. Over a small triangular area, termed the trigonum vesica, immediately above 
and behind the internal orifice of the urethra, the mucous membrane is firmly bound to 
the muscular coat, and is always smooth. Stretching behind the latter openings is a 
slightly curved ridge, the torus uretericus, forming the base of the trigone and produced 
by an underlying bundle of non-striped muscular fibers. (Figure 1-a) 
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When the bladder is illuminated the torus uretericus appears as a pale band and forms an 
important guide during the operation of introducing a catheter into the ureter. 
The orifices of the ureters are placed at the postero-lateral angles of the trigonum 
vesica, and are usually slit-like in form. In the contracted bladder, they are about 2.5 em. 
apart and about the same distance from the internal urethral orifice; in the distended 
viscus, these measurements may be increased to about 5 em. (Gray, 2000). 
2.1.4 Bladder Coats 
The bladder is composed of the four coats (Figure 2 -b): 
(1) The serous coat (tunica serosa) is a partial one, and is derived from the peritoneum. 
It invests the superior surface and the upper parts of the lateral surfaces, and is reflected 
from these on to the abdominal and pelvic walls. 
(2) The muscular coat (tunica muscularis) consists of three layers ofunstriped muscular 
fibers: an external layer composed of fibers having for the most part a longitudinal 
arrangement; a middle layer, in which the fibers are arranged, more or less, in a circular 
manner; and an internal layer, in which the fibers have a general longitudinal 
arrangement. 
(3) The submucous coat (tela submucosa) consists of a layer of areolar tissue, 
connecting together the muscular and mucous coats, and intimately united to the latter. 
(4) The mucous coat (tunica mucosa) is thin, smooth, and of a pale rose color. The 
epithelium covering it is of the transitional variety, consisting of a superficial layer of 
polyhedral flattened cells, each with one, two, or three nuclei; beneath these is a stratum 
of large club-shaped cells, with their narrow extremities directed downward and wedged 
in between smaller spindle-shaped cells, containing oval nuclei (Gray, 2000). 
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FIGURE 2: (a) INTERIOR OF THE URINARY BLADDER (b) BLADDER COATS 
CI TED FROM GRAY'S ANATOMY OF HUMAN BODY 
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2.1.5 Vessels and Nerves. 
The arteries supplying the bladder are the superior, middle, and inferior vesicle, derived 
from the anterior trunk of the hypogastric. The obturator and inferior gluteal arteries 
also supply small visceral branches to the bladder, and in the female additional branches 
are derived from the uterine and vaginal arteries. The veins form a complicated plexus 
on the inferior surface, and fundus near the prostate, and end in the hypogastric veins. 
The Lymphatic vessels of the bladder originate in two plexuses, an intra- and an 
extramuscular, it being generally admitted that the mucous membrane is devoid of 
lymphatics. The efferent vessels are arranged in two groups, one from the anterior and 
another from the posterior surface of the bladder. The vessels from the anterior surface 
pass to the external iliac glands, but in their course minute glands are situated. These 
minute glands are arranged in two groups, an anterior vesical, in front of the bladder, 
and a lateral vesical, in relation to the lateral umbilical ligament. The vessels from the 
posterior surface pass to the hypogastric, external, and common iliac glands; those 
draining the upper part of this surface traverse the lateral vesical glands. 
The nerves of the bladder are (1) fine medullated (myelinated) fibers from the third and 
fourth sacral nerves, and (2) non-medullated (non-myelinated) fibers from the 
hypogastric plexus. They are connected with ganglia in the outer and submucous coats 
and are finally distributed, all as non-medullated fibers, to the muscular layer and 
epithelial lining of the viscus (Gray, 2000). 
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2.2 EPIDEMIOLOGY OF BLADDER CANCER 
2.2.1 Introduction 
Bladder cancer constitutes the most frequent malignant neoplasia in urinary tract. The 
incidence, morbidity, and mortality rates associated with bladder cancer vary by 
country, ethnicity, gender, and age (Jemal eta/., 2005). 
Bladder cancer, considered as one of the first cancers associated with industrialization, 
it is increasing in incidence in the modem world. In USA there were 63,210 newly 
diagnosed cases of bladder cancer and 13,180 deaths due to this disease in 2005, 
making it the fourth most commonly diagnosed cancer in the United States (Gwynn 
and Clark, 2006), (Jemal eta/., 2005). 
2.2.2 Age and sex distribution 
According to surveillance, epidemiology, and outcome data of the United State National 
Cancer Institute, white individual had an incidence of 17.7 per 100,000 population, and 
black had an incidence of9.2 per 100,000 population. Between 1990 and 1997, the age-
adjusted incidence for Hispanics was 8.0 per 100,000 population, for Asians it was 7.5 
per I 00,000 and for American Indians it was 2.6 per 100,000 (Ries et al., 2000). 
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Men have a risk that is at least three times greater than that of women. The age-adjusted 
incidence rate for men is 28.2 per 100,000 and for women it is 7.5 per 100,000. 
Moreover, the lifetime risk of having bladder cancer is 3.40% for men and 1.18% for 
women (Ries et a/., 2000). 
An individual 65 years and older has an incidence of 110.8 per 100,000 population, 
while younger persons has an incidence of only 6.4 per 100,000 population. 
Statistically, the risk for a 70-year-old is two to three times greater than that for a person 
55 to 69 years old, and 15 to 20 times greater than for a person 30 to 54 years old. 
In the United States and Canada, an average of 11 years of life are lost per bladder 
cancer death.l,9 Between 1990 and 1997, White persons had an age-adjusted mortality 
rate of 3.3 per 100,000, while Black persons had a mortality rate of 3.1 per 100,000 
(Miller et a/., 2006). 
2.2.3 Occupational Exposure 
Bladder cancer is strongly linked to occupational and environmental exposure to 
chemicals. The development of the disease is associated with the excretion of 
carcinogenic metabolites in the urine. In the early 1950s an investigation of bladder 
cancers in workers in British chemical industries showed that individuals exposed to 
f3 
aromatic amines especially benzidine and -naphtylamine had a 30 times greater risk of 
developing bladder cancer than the general population. The average latent period for the 
development of the disease was more than 15 years (van der Meijden, 1998). 
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Such exposures were related to work places in the chemical industry, involving 
production and processing of classical aromatic amines, and in the rubber industry. 
Occupational bladder cancer has also been observed in dyers, painters and hairdressers. 
Even some occupations with much lower exposures to carcinogenic aromatic amines, 
like coke oven workers or workers in the rubber industry after the ban on fJ-
naphthylamine, are at risk. In these occupations, exposure to complex mixtures of 
substances containing combustion products (e.g. polycyclic aromatic hydrocarbons) or 
nitrosamines is common (Golka eta/., 2004). 
2.2.4 Tobacco smoking 
Cigarette smoking is the leading cause of bladder cancer nowadays, with relative risk 
estimates averaging 3.0 across 74 epidemiologic studies. Putative carcinogenic 
constituents of tobacco smoke include polycyclic aromatic hydrocarbons (PAHs), N-
nitroso compounds, arylamines, heterocyclic amines, various epoxides and numerous 
others. Metabolic activation of these compounds and subsequent binding of their 
reactive metabolites to DNA represent key tumourigenic events(Karagas eta/., 2005). 
Exposure of the bladder mucosal epithelium to tobacco-related carcinogens may be 
modulated by the activity of the glutathione-S-transferases, which are involved in the 
conjugation of reduced GSH with reactive electrophiles generated from tobacco 
smoke.(Karagas et a/., 2005). 
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Esteban and coworker found that the duration and intensity of cigarette smoking 
independently increased the risk of bladder cancer. They confirmed that smoking 
cessation reduces the risk and that the effect is proportional to the length of time interval 
since quitting. They detected a statistically significant difference in the risk of bladder 
cancer between men and women who smoked. Furthermore, they also demonstrated 
that, when comparable amounts of cigarettes were smoked, women who smoked had 
higher levels of 3- and 4-aminobiphenyl (ABP) hemoglobin adducts than men who 
smoked. This observation is important because arylamines (including ABPs), which are 
found in cigarette smoke, are believed to play a major role in smoking-induced bladder 
carcinogenesis (Castelao eta!., 2001). 
2.2.5 Drugs, alcohol and dietary factors 
In the Mediterranean region of France where bladder cancer mortality and incidence are 
high, a case-control study with 219 male incident cases and 794 randomized, male 
population controls was carried out in 1987-89 to investigate bladder cancer risk factors 
and more specifically, regional factors. This investigation confirms the role of tobacco 
and of certain occupational exposures in bladder carcinogenesis. There was a significant 
dose-response relationship with lifelong coffee drinking and alcohol consumption; 
however, the risk estimates were only significantly elevated for the heaviest drinkers. 
The intake of saccharin was not associated with risk of bladder cancer. Infrequent 
consumption of carrots, spinach, and marrows conferred an increased risk, suggesting a 
protective effect of vitamin A. Finally, this investigation results in some new 
hypotheses. The study of residences and birthplaces has revealed a lower risk for those 
who have lived in a non-Mediterranean area and a higher risk for those born in a 
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Mediterranean area. These features might be explained by some Mediterranean dietary 
habits, such as a high consumption of spices (Momas et al., 1994). 
2.2.6 Other factors 
Chronic irritation of the bladder mucosa predisposes to the development of bladder 
cancer. Longstanding bladder calculi associated with BPH or indwelling catheters in 
those with spinal injuries are associated with an increased risk of cancer bladder and 
most often of the squamous cell variety. Pelvic irradiation for extravesical pelvic 
malignancies is another predisposing factor(Ries et a/., 2000). 
Another potential causative agent, particularly in Africa, is Schistosoma haematobium. 
This parasite is presumed to cause cancer by invoking chronic inflammation and 
interfering with the metabolism of cigarette smoke-related bladder mutagens. 
Interestingly, most cancers caused by schistosomiasis are squamous cell in origin and 
appear in younger patient (Bedwani eta/., 1998). 
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2.3 PATHOLOGY OF BLADDER CANCER 
2.3.1 Introduction 
Histopathologic features of urothelial carctnoma of the bladder have prognostic 
significance. Recognition of invasion and of its level of penetration into the bladder 
wall forms the basis of pathologic staging and patient's therapy(Bircan et a!., 2005). 
In general more than 90% of bladder carcinomas are transitional cell carcinomas 
derived from the uroepithelium, about 6% to 8% are squamous cell variety, and 2% are 
adenocarcinomas (Mostofi et a!., 1990). 
Studies from United States, shows 85% to 95% of bladder cancers are transitional-cell 
carcinomas. Mixed tumours containing squamous-cell carcinoma and adenocarcinoma 
elements are reported at various rates between I 0% and 30%. Pure squamous-cell 
carcinoma occurs in less than 3% of bladder cancers in the United States, but in areas 
where bilharziasis is endemic ( eg, Egypt), squamous-cell carcinoma of the bladder is the 
most common malignancy (Mahamooth and A wang, 1983). 
Adenocarcinoma accounts for 2% of bladder cancers, most occurs on the trigone of the 
bladder. A particular subset of adenocarcinomas arising from the urachus remnant are 
usually locate over the dome of the bladder. About 70% to 80% of bladder cancers 
occur on the lateral or posterior walls of the bladder, and 20%, on the trigone. Thirty 
percent of tumours are multi focal at diagnosis. (Pode eta/. , 1987). 
14 
According to another study(Mahamooth and A wang, 1983) The commonest localization 
of bladder cancer are the side wall of the bladder , followed by the posterior wall , the 
bladder neck, the ureteric orifices and the Trigone. 
2.3.2 Staging of Bladder Tumour 
The stage of the cancer is the most important deciding factor by which treatment will be 
instituted. The clinical staging of carcinoma of the bladder is determined by the depth of 
invasion of the bladder wall by the tumour. This determination requires a cystoscopic 
examination that includes a biopsy, and examination under anesthesia to assess the size 
and mobility of palpable masses, the degree of induration of the bladder wall, and the 
presence of extravesical extension or invasion of adjacent organs. 
Clinical staging, even when computed tomographic and/or magnetic resonance imaging 
scans and other imaging modalities are used, often underestimates the extent of tumour, 
particularly in cancers that are less differentiated and more deeply invasive (Skinner, 
1977). 
The most accurate and the latest staging system is the TNM system. It is generally 
accepted for staging bladder tumours (Figure 3) 
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FIGURE 3: STAGING IN BLADDER CANCER, 
T3a 
'I...,;,.,~------Mucosa 
L--~----Lamina propria 
""'-~---Superficial muscle 
~------ Oeep muscle 
{CITED FROM: BMJ. / 999 Mar 27;318{7187):875-6) 
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2.3.2.1 TNM staging of bladder cancer 
Primary tumour (T) 
• TX: Primary tumour cannot be assessed 
• TO: No evidence of primary tumour 
• Ta: Noninvasive papillary carcinoma 
• Tis: Carcinoma in situ: "flat tumour" 
• Tl: Tumour invades subepithelial connective tissue 
• T2: Tumour invades muscle 
• pT2a: Tumour invades superficial muscle (inner half) 
• pT2b: Tumour invades deep muscle (outer half) 
• T3: Tumour invades perivesical tissue 
• pT3a: Microscopically 
• pT3b: Macroscopically (extravesical mass) 
• T4: Tumour invades any of the following: prostate, uterus, vagina, pelvic wall, 
or abdominal wall 
• T 4a: Tumour invades the prostate, uterus, vagina 
• T4b: Tumour invades the pelvic wall, abdominal wall 
Regional lymph nodes (N) 
• NX: Regional lymph nodes cannot be assessed 
• NO: No regional lymph node metastasis 
• N 1: Metastasis in a single lymph node, 2 em or less in greatest dimension 
• N2: Metastasis in a single lymph node, more than 2 em but not more than 5 em 
in greatest dimension; or multiple lymph nodes, none more than 5 em in greatest 
dimension 
• N3: Metastasis in a lymph node, more than 5 em in greatest dimension 
Distant metastasis (M) 
• 
• 
• 
MX: Distant metastasis cannot be assessed 
MO: No distant metastasis 
M 1 : Distant metastasis 
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2.3.2.2 AJCC stage groupings 
Stage Oa 
• Ta, NO, MO 
Stage Ois 
• Tis, NO, MO 
Stage I 
• Tl, NO, MO 
Stage II 
• T2a, NO, MO 
• T2b, NO, MO 
Stage III 
• T3a, NO, MO 
• T3b, NO, MO 
• T4a, NO, MO 
Stage IV 
• T4b, NO, MO 
• AnyT, Nl, MO 
• AnyT, N2, MO 
• AnyT, N3, MO 
• Any T, any N, Ml 
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A tumour that is limited to the mucosa and lies flat is Tis (carcinoma in situ); a tumour 
that is papillary and limited to the mucosa is pTa and a tumour that penetrates the 
lamina propria but not the muscle layer is pTI. If the tumour invades muscle it may be 
staged from pT2 to pT4 according to the depth of infiltration of muscle tissue or the 
extent to which the surrounding tissue is affected. Tumours that invade the bladder 
muscle are highly malignant and have a strong potential to metastasise preferentially to 
regional lymph nodes, lungs, liver, and bone(van der Meijden, 1998). Therefore 
computed tomography, chest x rays, magnetic resonance imaging, and bone scanning 
are advised. 
2.3.3 Grading of Bladder Tumour 
Both the grade and stage at diagnosis of cancer bladder have extremely important 
prognostic and therapeutic implications. 
The grade is determined by pathology tests, showing how abnormal or aggressive the 
cells of biopsy specimens appear , and how closely a tumour resembles normal tissue of 
its same type. Differentiation is another term used to describe the degree of an abnormal 
cell's resemblance to it's normal counterpart. Tumour cells are described as well 
differentiated when they look much like normal cells of the same type and are able to 
carry out some functions of normal cells. Poorly differentiated and undifferentiated 
tumour cells are disorganized and abnormal looking. 
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As a rule, the grade of a tumour corresponds to its rate of growth or aggressiveness. An 
undifferentiated or high-grade tumour grows more quickly than a well differentiated or 
a low-grade one. A large tumour can be low grade, a small tumour can be high grade. 
Carcinoma in situ is a potentially dangerous and usually high grade tumour, and CIS 
patients are at greater risk for progression and must be monitored closely. 
The World Health Organization (WHO) classification recognizes three grades of 
urothelial carcinoma. Grade 1 represents well-differentiated papillary tumours with 
limited atypia and mitoses. At the other end, Grade 3 lesions show a marked increase in 
the cell layers and cell size, and noticeable pleomorphism and mitoses are prominent. 
Tumour grade appears to correlate significantly with the natural history of transitional 
cell carcinoma. The higher the grade of the diagnosis, the higher the incidence of death 
from the disease within two years (Herr, 1993 ). 
Epidemiological data illustrating the distribution and topography of bladder cancer 
between 1990 and 1993 show that 3 8% of all neoplasms were G 1 and G2 transitional 
cell carcinoma. G3 or G4 carcinoma was only seen in 23%. 
Nontransitional cell histologies, however, all behave very aggressively and, in general, 
are less responsive to treatments other than extirpative surgery. In general, the 
prognoses of patients and the choice of treatments depend on the aggressiveness and 
grade of the tumour. 
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2.3.4 Genetics of Bladder Tumour 
The role of oncogenes is under intense investigation. Cytogenetic analysis has provided 
strong evidence that loss of a suppressor gene or genes on chromosome 9 is frequently 
involved in the genesis of bladder cancer. Mutations of the p53 tumour suppressor gene 
have been identified in 50% of high-grade and stage bladder tumours, and are important 
in determining survival after neo-adjuvant chemotherapy on a type 3 level of evidence. 
Oncogenes of the ras gene family have been found in bladder cancer. A correlation has 
been shown between the expression of ras protein and high histological grade. In 
addition, an association between c-myc oncoprotein expression and recurrence or 
invasion in superficial tumours has been shown. Methylation of the c-myc oncogene 
may also correlate with stage and grade. Newer and increasingly important prognostic 
indicators may be utilized to select patients who stand to benefit from chemotherapy. In 
the context of well conducted clinical protocols, investigational prognostic factors such 
as DNA ploidy, p53, mdr 1, retinoblastoma gene product, NM23 RNA levels, and T138 
surface antigen expression may be used to select patients for specific therapies( de Braud 
et al., 2002). 
Expression of the tumour suppressor gene p53 also has been associated with an adverse 
prognosis for patients with invasive bladder cancer. A retrospective study of 243 
patients treated by radical cystectomy found that the presence of nuclear p53 was an 
independent predictor for recurrence among patients with stage Tl, T2, or T3 tumours. 
Another retrospective study showed p53 expression to be of prognostic value when 
considered with stage or labeling index (Esrig et al., 1994). 
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The detection of circulating tumour cells and micrometastases may have important 
prognostic and therapeutic implications. Because their numbers can be very small, these 
tumour cells are not easily detected using conventional methods. In the last decade, 
molecular techniques have been widely used for the detection of occult tumour cells 
The molecular detection of occult tumour cells can be accomplished by PCR 
amplification of tumour-specific abnormalities present in the DNA or mRNA of 
malignant cells. The other main PCR strategy for the detection of CTC and 
micrometastases involves amplification of tissue-specific mRNA. This latter method 
was often applied to solid tumours, whereas the former was occasionally used. PCR was 
shown to be superior to conventional techniques in detecting occult tumour cells, 
allowing the identification of 1 malignant cell mixed with 1 to 1 0 million normal cells. 
In some reports, PCR is shown to be a strong predictor of outcome. The molecular 
detection of circulating tumour cells and micrometastases in solid tumours can be 
accomplished using highly sensitive PCR assays (Ghossein et al., 1999) 
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2.4 CLINICAL PRESENTATION 
The diagnosis of bladder cancer is often delayed due to the similarity of symptoms to 
those of benign disorders ( eg, urinary tract infection, interstitial cystitis, prostatitis, and 
the passage of renal calculi). Furthennore, symptoms are often intermittent. 
The most common presenting symptom is hematuria, which is typically intermittent, 
gross, painless, and present throughout micturition. Gross, painless hematuria is a 
common presenting symptom of bladder cancer and occurs in 80% of cases 
(Mahamooth and A wang, 1983). 
The degree of blood in the unne is not predictive of the probability of cancer. 
Microscopic hematuria is present in up to one-fifth of the general population, and 
benign causes are predominantly, but not exclusively, responsible. Bladder cancer can, 
however, mimic urinary tract infection or prostatism. Irritative symptoms are more 
frequently associated with aggressive bladder tumours, such as grade III carcinoma or 
carcinoma in situ. Fortunately, urinary cytology is positive in more than 80 percent of 
patients with high-grade transitional cell carcinoma (Lamm and Torti, 1996). 
In an adult, especially over 50 years of age, with asymptomatic gross haematuria, 
microscopic haematuria, or irritative voiding symptoms, it is recommended that the 
diagnosis of bladder cancer be considered. 
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For tumours overlying the urethral orifice the presenting symptom may be flank pain or 
pyelonephritis from obstruction. These findings are also suggestive of invasive cancer. 
Symptoms of advanced disease such as pain, abdominal mass or weight loss may be 
present as well. 
Patients with advanced bladder cancer may present with pelvic pain due to an enlarging 
tumour or nerve root compression. Lower extremity edema may be the result of 
lymphatic or venous obstruction. Patients who present with metastatic disease may have 
bone pain. 
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